We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Cortexyme Bets on P. Gingivalis Toxin Disrupter to Slow Alzheimer’s Progression
Cortexyme Bets on P. Gingivalis Toxin Disrupter to Slow Alzheimer’s Progression
Cortexyme isn’t letting a missed primary endpoint stifle its conviction that P. gingivalis, the bacteria that causes periodontal disease, is a root cause of Alzheimer’s disease (AD) and that its oral medication atuzaginstat can put the brakes on both cognitive and functional degeneration.